Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan
· Delayed Price · Currency is JPY 4,545.00
-10.00 (-0.22%)
Apr 28, 2026, 3:30 PM JST
Kissei Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 188,400 | 164,586 | 156,266 | 121,792 | 117,826 | 112,984 | Upgrade
|
| Market Cap Growth | 16.90% | 5.32% | 28.31% | 3.36% | 4.29% | -13.03% | Upgrade
|
| Enterprise Value | 144,261 | 122,521 | 115,492 | 77,037 | 78,311 | 68,996 | Upgrade
|
| Last Close Price | 4545.00 | 3713.50 | 3324.47 | 2425.93 | 2274.71 | 2133.27 | Upgrade
|
| PE Ratio | 13.47 | 13.76 | 14.00 | 11.57 | 9.12 | 21.38 | Upgrade
|
| Forward PE | 15.71 | 17.88 | 14.26 | 10.90 | 36.67 | 28.42 | Upgrade
|
| PS Ratio | 1.98 | 1.86 | 2.07 | 1.81 | 1.80 | 1.64 | Upgrade
|
| PB Ratio | 0.87 | 0.78 | 0.71 | 0.63 | 0.58 | 0.51 | Upgrade
|
| P/TBV Ratio | 0.88 | 0.80 | 0.72 | 0.63 | 0.59 | 0.52 | Upgrade
|
| P/FCF Ratio | - | 81.72 | - | - | 2677.87 | - | Upgrade
|
| P/OCF Ratio | - | 25.24 | - | - | 76.86 | - | Upgrade
|
| PEG Ratio | 2.76 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | Upgrade
|
| EV/Sales Ratio | 1.51 | 1.39 | 1.53 | 1.14 | 1.20 | 1.00 | Upgrade
|
| EV/EBITDA Ratio | 52.65 | 11.79 | 13.96 | 25.97 | 33.64 | 14.83 | Upgrade
|
| EV/EBIT Ratio | - | 21.22 | 28.75 | - | - | 45.81 | Upgrade
|
| EV/FCF Ratio | - | 60.83 | - | - | 1779.80 | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.46 | 0.12 | 0.16 | 0.50 | 0.70 | 0.37 | Upgrade
|
| Debt / FCF Ratio | - | 0.64 | - | - | 37.27 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.21 | -0.22 | -0.20 | -0.25 | -0.25 | -0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | -16.59 | -4.56 | -5.39 | -16.22 | -22.13 | -9.18 | Upgrade
|
| Net Debt / FCF Ratio | - | -23.52 | 15.49 | 5.48 | -1170.73 | 12.30 | Upgrade
|
| Asset Turnover | 0.38 | 0.35 | 0.31 | 0.29 | 0.26 | 0.28 | Upgrade
|
| Inventory Turnover | 1.85 | 1.73 | 1.56 | 1.68 | 1.75 | 2.17 | Upgrade
|
| Quick Ratio | 3.28 | 4.68 | 4.17 | 4.79 | 4.01 | 3.70 | Upgrade
|
| Current Ratio | 4.50 | 6.45 | 5.92 | 6.73 | 5.30 | 5.10 | Upgrade
|
| Return on Equity (ROE) | 6.66% | 5.55% | 5.43% | 5.36% | 6.17% | 2.60% | Upgrade
|
| Return on Assets (ROA) | -0.53% | 1.43% | 1.04% | -0.31% | -0.35% | 0.38% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.07% | 2.61% | 1.94% | -0.60% | -0.68% | 0.69% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.90% | 2.50% | 1.70% | -0.60% | -0.60% | 0.60% | Upgrade
|
| Earnings Yield | 7.50% | 7.27% | 7.14% | 8.64% | 10.97% | 4.68% | Upgrade
|
| FCF Yield | - | 1.22% | -1.84% | -7.21% | 0.04% | -3.07% | Upgrade
|
| Dividend Yield | 2.64% | 2.69% | 2.47% | 3.30% | 2.46% | 2.53% | Upgrade
|
| Payout Ratio | - | 31.78% | 33.35% | 29.78% | 19.63% | 46.83% | Upgrade
|
| Buyback Yield / Dilution | 4.74% | 3.62% | 1.86% | - | 1.18% | 0.11% | Upgrade
|
| Total Shareholder Return | 7.37% | 6.31% | 4.32% | 3.30% | 3.64% | 2.64% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.